KALA KALA BIO, Inc.
Nasdaq · SEC CIK 1479419 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $1.30M 6 sales by 6 insiders
- Filings on record
- 124 since 2021-10-19, latest 2025-12-22
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| BAKER JULIAN | Former 10% owner | — | $1.06M |
| Iwicki Mark T | Dir | — | $125.5K |
| Bazemore Todd | Dir | — | $39.6K |
| Brazzell Romulus K | SEE REMARKS | — | $38.8K |
| Reumuth Mary | CFO | — | $27.5K |
| Kharabi Darius | Chief BUSINESS Off | — | $17.3K |
Transactions 127
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-01-06 | 2023-01-04 | KALA | Kharabi Darius | Chief BUSINESS Off | A - Grant | $0.00 | +9,525 | 15.4K | +161% | $0 | |
| 2022-10-28 | 2022-10-26 | KALA | Reumuth Mary | CFO | S - Sale | $6.51 | -194 | 2,418 | -7% | -$1,263 | |
| 2022-10-28 | 2022-10-26 | KALA | Iwicki Mark T | CEO, Dir | S - Sale | $6.52 | -561 | 4,464 | -11% | -$3,658 | |
| 2022-10-28 | 2022-10-26 | KALA | Trachtenberg Eric | SEE REMARKS | S - Sale | $6.52 | -194 | 2,030 | -9% | -$1,265 | |
| 2022-10-28 | 2022-10-26 | KALA | Brazzell Romulus K | SEE REMARKS | S - Sale | $6.51 | -261 | 5,809 | -4% | -$1,699 | |
| 2022-10-28 | 2022-10-26 | KALA | Bazemore Todd | SEE REMARKS | S - Sale | $6.51 | -214 | 2,097 | -9% | -$1,393 | |
| 2022-06-29 | 2022-06-27 | KALA | Iwicki Mark T | CEO, Dir | S - Sale | $0.37 | -7,975 | 251.2K | -3% | -$2,951 | |
| 2022-06-29 | 2022-06-27 | KALA | Brazzell Romulus K | SEE REMARKS | S - Sale | $0.37 | -3,144 | 285.2K | -1% | -$1,163 | |
| 2022-06-29 | 2022-06-27 | KALA | Bazemore Todd | SEE REMARKS | S - Sale | $0.37 | -3,092 | 115.5K | -3% | -$1,144 | |
| 2022-06-29 | 2022-06-27 | KALA | Reumuth Mary | CFO | S - Sale | $0.37 | -2,613 | 130.6K | -2% | -$966.81 | |
| 2022-06-29 | 2022-06-27 | KALA | Trachtenberg Eric | SEE REMARKS | S - Sale | $0.37 | -2,613 | 111.2K | -2% | -$966.81 | |
| I | 2022-05-26 | 2022-05-26 | KALA | Kolchinsky Peter | 10% | S - Sale | $0.36 | -1.01M | 7.04M | -13% | -$362.0K |
| MI | 2022-05-25 | 2022-05-23+ | KALA | Shah Rajeev M. | 10% | S - Sale | $0.5262 | -2.83M | 9.48M | -23% | -$1.49M |
| D | 2022-01-05 | 2022-01-04 | KALA | Iwicki Mark T | CEO, Dir | S - Sale | $1.30 | -9,518 | 259.2K | -4% | -$12.4K |
| D | 2022-01-05 | 2022-01-04 | KALA | Brazzell Romulus K | SEE REMARKS | S - Sale | $1.30 | -3,504 | 288.3K | -1% | -$4,555 |
| D | 2022-01-05 | 2022-01-04 | KALA | Trachtenberg Eric | SEE REMARKS | S - Sale | $1.30 | -2,850 | 113.8K | -2% | -$3,705 |
| D | 2022-01-05 | 2022-01-04 | KALA | Reumuth Mary | CFO | S - Sale | $1.30 | -2,850 | 133.2K | -2% | -$3,705 |
| D | 2022-01-05 | 2022-01-04 | KALA | Bazemore Todd | SEE REMARKS | S - Sale | $1.30 | -3,454 | 118.6K | -3% | -$4,490 |
| D | 2021-11-17 | 2021-11-15 | KALA | Kharabi Darius | Chief BUSINESS Off | A - Grant | — | +295.7K | 295.7K | New | — |
| D | 2021-11-17 | 2021-11-15 | KALA | Blumenkranz Mark S. | Dir | A - Grant | — | +157.8K | 157.8K | New | — |
| DMI | 2021-11-17 | 2021-11-15 | KALA | Blumenkranz Mark S. | Dir | A - Grant | — | +5.18M | 39.0K | New | — |
| M | 2021-10-28 | 2021-10-26+ | KALA | Chen Hongming | CSO | S - Sale | $1.81 | -30.5K | 225.6K | -12% | -$55.3K |
| 2021-10-28 | 2021-10-26 | KALA | Trachtenberg Eric | SEE REMARKS | S - Sale | $1.80 | -9,449 | 116.7K | -7% | -$17.0K | |
| 2021-10-28 | 2021-10-26 | KALA | Reumuth Mary | CFO | S - Sale | $1.80 | -9,449 | 136.1K | -6% | -$17.0K | |
| 2021-10-28 | 2021-10-26 | KALA | Brazzell Romulus K | Chief MEDICAL Off | S - Sale | $1.80 | -12.8K | 291.8K | -4% | -$23.0K | |
| 2021-10-28 | 2021-10-26 | KALA | Bazemore Todd | COO | S - Sale | $1.80 | -12.5K | 122.0K | -9% | -$22.6K | |
| 2021-10-28 | 2021-10-26 | KALA | Iwicki Mark T | CEO, Dir | S - Sale | $1.80 | -27.6K | 268.7K | -9% | -$49.7K |
Purchase Sale Sale after option exercise All abbreviations